Literature DB >> 20439258

Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.

Rui Wang1, Stephen W Lagakos, Robert J Gray.   

Abstract

While the commonly used log-rank test for survival times between 2 groups enjoys many desirable properties, sometimes the log-rank test and its related linear rank tests perform poorly when sample sizes are small. Similar concerns apply to interval estimates for treatment differences in this setting, though their properties are less well known. Standard permutation tests are one option, but these are not in general valid when the underlying censoring distributions in the comparison groups are unequal. We develop 2 methods for testing and interval estimation, for use with small samples and possibly unequal censoring, based on first imputing survival and censoring times and then applying permutation methods. One provides a heuristic justification for the approach proposed recently by Heinze and others (2003, Exact log-rank tests for unequal follow-up. Biometrics 59, 1151-1157). Simulation studies show that the proposed methods have good Type I error and power properties. For accelerated failure time models, compared to the asymptotic methods of Jin and others (2003, Rank-based inference for the accelerated failure time model. Biometrika 90, 341-353), the proposed methods yield confidence intervals with better coverage probabilities in small-sample settings and similar efficiency when sample sizes are large. The proposed methods are illustrated with data from a cancer study and an AIDS clinical trial.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439258      PMCID: PMC2950789          DOI: 10.1093/biostatistics/kxq021

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  6 in total

1.  Exact log-rank tests for unequal follow-up.

Authors:  Georg Heinze; Michael Gnant; Michael Schemper
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

2.  A general class of nonparametric tests for survival analysis.

Authors:  M P Jones; J Crowley
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

3.  Likelihood approaches to the non-parametric two-sample problem for right-censored data.

Authors:  James F Troendle; Kai F Yu
Journal:  Stat Med       Date:  2006-07-15       Impact factor: 2.373

4.  Permutational distribution of the log-rank statistic under random censorship with applications to carcinogenicity assays.

Authors:  G Heimann; G Neuhaus
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

5.  Response to antiretroviral therapy after a single, peripartum dose of nevirapine.

Authors:  Shahin Lockman; Roger L Shapiro; Laura M Smeaton; Carolyn Wester; Ibou Thior; Lisa Stevens; Fatima Chand; Joseph Makhema; Claire Moffat; Aida Asmelash; Patrick Ndase; Peter Arimi; Erik van Widenfelt; Loeto Mazhani; Vladimir Novitsky; Stephen Lagakos; Max Essex
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

6.  Covariate analysis of survival data: a small-sample study of Cox's model.

Authors:  M E Johnson; H D Tolley; M C Bryson; A S Goldman
Journal:  Biometrics       Date:  1982-09       Impact factor: 2.571

  6 in total
  11 in total

1.  The use of permutation tests for the analysis of parallel and stepped-wedge cluster-randomized trials.

Authors:  Rui Wang; Victor De Gruttola
Journal:  Stat Med       Date:  2017-05-02       Impact factor: 2.373

2.  Sizing clinical trials when comparing bivariate time-to-event outcomes.

Authors:  Tomoyuki Sugimoto; Toshimitsu Hamasaki; Scott R Evans; Takashi Sozu
Journal:  Stat Med       Date:  2017-01-24       Impact factor: 2.373

3.  Weighted logrank tests for interval censored data when assessment times depend on treatment.

Authors:  Michael P Fay; Joanna H Shih
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

4.  The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.

Authors:  Jose Antonio Perez-Simón; Rodrigo Martino; Rocío Parody; Mónica Cabrero; Lucía Lopez-Corral; David Valcarcel; Carmen Martinez; Carlos Solano; Lourdes Vazquez; Francisco J Márquez-Malaver; Jordi Sierra; Dolores Caballero
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

5.  Radiotherapy influences local control in patients with desmoplastic melanoma.

Authors:  Tobin Strom; Jimmy J Caudell; Dale Han; Jonathan S Zager; Daohai Yu; C Wayne Cruse; Suroosh S Marzban; Jane L Messina; Andy M Trotti; Vernon K Sondak; Nikhil G Rao
Journal:  Cancer       Date:  2013-10-18       Impact factor: 6.860

6.  Randomization inference with general interference and censoring.

Authors:  Wen Wei Loh; Michael G Hudgens; John D Clemens; Mohammad Ali; Michael E Emch
Journal:  Biometrics       Date:  2019-10-15       Impact factor: 2.571

7.  Bayesian reconstruction of transmission trees from genetic sequences and uncertain infection times.

Authors:  Hesam Montazeri; Susan Little; Mozhgan Mozaffarilegha; Niko Beerenwinkel; Victor DeGruttola
Journal:  Stat Appl Genet Mol Biol       Date:  2020-10-21

8.  Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable Modeling.

Authors:  Stefanie Hieke; Axel Benner; Richard F Schlenk; Martin Schumacher; Lars Bullinger; Harald Binder
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

9.  Inaccuracy of the log-rank approximation in cancer data analysis.

Authors:  Nimrod Rappoport; Ron Shamir
Journal:  Mol Syst Biol       Date:  2019-08       Impact factor: 11.429

10.  Longitudinal association of cytokine-producing CMV-specific T cells with frailty in HIV-infected and -uninfected men who have sex with men.

Authors:  Weiying Zhang; Huifen Li; Jay H Bream; Tricia L Nilles; Sean X Leng; Joseph B Margolick
Journal:  Immun Ageing       Date:  2022-03-07       Impact factor: 9.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.